A retrospective study investigating efficacy of dolutegravir based monotherapy or dual therapy in patients with HIV-1 infection

Trial Profile

A retrospective study investigating efficacy of dolutegravir based monotherapy or dual therapy in patients with HIV-1 infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2016

At a glance

  • Drugs Dolutegravir (Primary) ; Abacavir; Atazanavir; Darunavir/ritonavir; Lamivudine; Maraviroc; Rilpivirine; Ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jan 2016 New trial record
    • 27 Dec 2015 Results published in the Journal of Antimicrobial Chemotherapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top